title: Experimental ochratoxicosis in broiler chickens.
abstract: This study describes the toxicity signs that developed when the diet of male broiler chickens was artificially contaminated with different levels of the mycotoxin ochratoxin A (OTA). Chicks were assigned randomly to three groups of 80 chicks that were fed a diet containing 0 parts per billion (ppb) (control, group 1), 400 ppb (group 2) or 800 ppb (group 3) OTA from day 1 to 5 weeks of age. Signs of ochratoxicosis were assessed on the basis of changes in the following criteria: body weight, relative weights of two representative internal organs (gizzard and thymus), feed consumption, feed conversion ratio, mortality, thyroid activity, blood profile, humoral and cell mediated immunity. Feeding OTA at levels of 400 and 800 ppb (groups 2 and 3) significantly decreased the body weight, thymus weight, feed consumption, feed conversion ratio and thyroxine concentration (P < 0.05). The OTA groups developed anaemia manifested by a significant decrease in the red blood cell count, packed cell volume percentage and haemoglobin concentration (P < 0.05). By the end of the experiment both groups that received OTA showed a 37% reduction in red blood cell count compared with the control group. Furthermore, a significant decrease in the white blood cell count, humoral immune response and cell-mediated immunity was found in both groups fed ochratoxin compared with the control group (P < 0.05). The reduction in the above parameters was more noticeable with time and was proportional to the level of OTA exposure. A significant increase in relative gizzard weight, cumulative mortality and triiodothyronine concentration was found in OTA-fed chicks (P < 0.05). These data provide a description of ochratoxicosis in broilers that should be useful in diagnosis and in improved understanding of the practical implications on broiler performance and health, a problem that can threaten the poultry industry.
authors.affiliation: Biological Applications Department, Nuclear Research Center, Atomic Energy Authority, Abou-Zaabal, Egypt. m_elaroussi@yahoo.com
authors.forename: M A
authors.initials: MA
authors.lastname: Elaroussi
authors.forename: F R
authors.initials: FR
authors.lastname: Mohamed
authors.forename: E M
authors.initials: EM
authors.lastname: El Barkouky
authors.forename: A M
authors.initials: AM
authors.lastname: Atta
authors.forename: A M
authors.initials: AM
authors.lastname: Abdou
authors.forename: M H
authors.initials: MH
authors.lastname: Hatab
mesh_terms: D000818:Animals; D002645:Chickens; D005895:Gizzard, Avian / Q000187:drug effects / Q000473:pathology; D008297:Male; D015651:Mycotoxicosis / Q000097:blood / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D009793:Ochratoxins / Q000633:toxicity*; D011201:Poultry Diseases / Q000097:blood / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D013950:Thymus Gland / Q000187:drug effects / Q000473:pathology; D013963:Thyroid Hormones / Q000378:metabolism
chemical_list: D009793:Ochratoxins; D013963:Thyroid Hormones; C025589:ochratoxin A